These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 32649973

  • 1. Mechanistic understanding of underperforming enteric coated products: Opportunities to add clinical relevance to the dissolution test.
    Amaral Silva D, Davies NM, Doschak MR, Al-Gousous J, Bou-Chacra N, Löbenberg R.
    J Control Release; 2020 Sep 10; 325():323-334. PubMed ID: 32649973
    [Abstract] [Full Text] [Related]

  • 2. Physiologically relevant dissolution conditions towards improved in vitro - in vivo relationship - A case study with enteric coated pantoprazole tablets.
    Amaral Silva D, Gomes Davanço M, Davies NM, Krämer J, de Oliveira Carvalho P, Löbenberg R.
    Int J Pharm; 2021 Aug 10; 605():120857. PubMed ID: 34229072
    [Abstract] [Full Text] [Related]

  • 3. In vitro dissolution of proton-pump inhibitor products intended for paediatric and geriatric use in physiological bicarbonate buffer.
    Liu F, Shokrollahi H.
    Int J Pharm; 2015 May 15; 485(1-2):152-9. PubMed ID: 25746736
    [Abstract] [Full Text] [Related]

  • 4. Evolution of a physiological pH 6.8 bicarbonate buffer system: application to the dissolution testing of enteric coated products.
    Liu F, Merchant HA, Kulkarni RP, Alkademi M, Basit AW.
    Eur J Pharm Biopharm; 2011 May 15; 78(1):151-7. PubMed ID: 21255647
    [Abstract] [Full Text] [Related]

  • 5. Regulating the pH of bicarbonate solutions without purging gases: Application to dissolution testing of enteric coated tablets, pellets and microparticles.
    Scott N, Patel K, Sithole T, Xenofontos K, Mohylyuk V, Liu F.
    Int J Pharm; 2020 Jul 30; 585():119562. PubMed ID: 32565282
    [Abstract] [Full Text] [Related]

  • 6. Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: The hidden role of bicarbonate buffer.
    Amaral Silva D, Al-Gousous J, Davies NM, Bou Chacra N, Webster GK, Lipka E, Amidon G, Löbenberg R.
    Eur J Pharm Biopharm; 2019 Sep 30; 142():8-19. PubMed ID: 31195131
    [Abstract] [Full Text] [Related]

  • 7. Use of bicarbonate buffer systems for dissolution characterization of enteric-coated proton pump inhibitor tablets.
    Shibata H, Yoshida H, Izutsu K, Goda Y.
    J Pharm Pharmacol; 2016 Apr 30; 68(4):467-74. PubMed ID: 27019275
    [Abstract] [Full Text] [Related]

  • 8. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
    Varum FJ, Merchant HA, Goyanes A, Assi P, Zboranová V, Basit AW.
    Int J Pharm; 2014 Jul 01; 468(1-2):172-7. PubMed ID: 24727141
    [Abstract] [Full Text] [Related]

  • 9. Dissolution Profiles of Immediate Release Products of Various Drugs in Biorelevant Bicarbonate Buffer: Comparison with Compendial Phosphate Buffer.
    Okamoto N, Higashino M, Yamamoto H, Sugano K.
    Pharm Res; 2024 May 01; 41(5):959-966. PubMed ID: 38653942
    [Abstract] [Full Text] [Related]

  • 10. Hierarchical Mass Transfer Analysis of Drug Particle Dissolution, Highlighting the Hydrodynamics, pH, Particle Size, and Buffer Effects for the Dissolution of Ionizable and Nonionizable Drugs in a Compendial Dissolution Vessel.
    Salehi N, Al-Gousous J, Mudie DM, Amidon GL, Ziff RM, Amidon GE.
    Mol Pharm; 2020 Oct 05; 17(10):3870-3884. PubMed ID: 32886520
    [Abstract] [Full Text] [Related]

  • 11. Predicting the gastrointestinal behaviour of modified-release products: utility of a novel dynamic dissolution test apparatus involving the use of bicarbonate buffers.
    Merchant HA, Goyanes A, Parashar N, Basit AW.
    Int J Pharm; 2014 Nov 20; 475(1-2):585-91. PubMed ID: 25195730
    [Abstract] [Full Text] [Related]

  • 12. Mechanistic analysis and experimental verification of bicarbonate-controlled enteric coat dissolution: Potential in vivo implications.
    Al-Gousous J, Ruan H, Blechar JA, Sun KX, Salehi N, Langguth P, Job NM, Lipka E, Loebenberg R, Bermejo M, Amidon GE, Amidon GL.
    Eur J Pharm Biopharm; 2019 Jun 20; 139():47-58. PubMed ID: 30872012
    [Abstract] [Full Text] [Related]

  • 13. Toward Mechanistic Design of Surrogate Buffers for Dissolution Testing of pH-Dependent Drug Delivery Systems.
    Blechar JA, Al-Gousous J, Wilhelmy C, Postina AM, Getto M, Langguth P.
    Pharmaceutics; 2020 Dec 10; 12(12):. PubMed ID: 33321933
    [Abstract] [Full Text] [Related]

  • 14. Dissolution of a Biopharmaceutics Classification System Class II Free Acid from Immediate Release Tablets Containing a Microenvironmental pH Modulator: Comparison of a Biorelevant Bicarbonate Buffering System with Phosphate Buffers.
    Haznar-Garbacz D, Hoc D, Garbacz G, Lachman M, Słomińska D, Romański M.
    AAPS PharmSciTech; 2022 Jul 26; 23(6):203. PubMed ID: 35882674
    [Abstract] [Full Text] [Related]

  • 15. Toward Biopredictive Dissolution for Enteric Coated Dosage Forms.
    Al-Gousous J, Amidon GL, Langguth P.
    Mol Pharm; 2016 Jun 06; 13(6):1927-36. PubMed ID: 27139040
    [Abstract] [Full Text] [Related]

  • 16. Physiological bicarbonate buffers: stabilisation and use as dissolution media for modified release systems.
    Fadda HM, Merchant HA, Arafat BT, Basit AW.
    Int J Pharm; 2009 Dec 01; 382(1-2):56-60. PubMed ID: 19666093
    [Abstract] [Full Text] [Related]

  • 17. Dissolution Kinetics of Nifedipine-Ionizable Polymer Amorphous Solid Dispersion: Comparison Between Bicarbonate and Phosphate Buffers.
    Sakamoto A, Sugano K.
    Pharm Res; 2021 Dec 01; 38(12):2119-2127. PubMed ID: 34931285
    [Abstract] [Full Text] [Related]

  • 18. Assessing the influence of media composition and ionic strength on drug release from commercial immediate-release and enteric-coated aspirin tablets.
    Karkossa F, Klein S.
    J Pharm Pharmacol; 2017 Oct 01; 69(10):1327-1340. PubMed ID: 28703304
    [Abstract] [Full Text] [Related]

  • 19. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
    Ibekwe VC, Fadda HM, Parsons GE, Basit AW.
    Int J Pharm; 2006 Feb 03; 308(1-2):52-60. PubMed ID: 16356670
    [Abstract] [Full Text] [Related]

  • 20. Gastro-resistant characteristics of GRAS-grade enteric coatings for pharmaceutical and nutraceutical products.
    Czarnocka JK, Alhnan MA.
    Int J Pharm; 2015 Feb 03; 486(1-2):167-74. PubMed ID: 25796126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.